Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans A Renee Stewart

Reference

• Barkan A., Mertz JE. DNA sequence analysis of simian virus 40 mutants with deletions mapping in the leader region of the late mRNAs: mutants with deletions similar in size and position exhibit varied phenotypes. J Virol 1981; 37: 730–737
   PubMed Web of Science ®Google Scholar
• Bergsagel D. J., Finegold M. J., Butel J. S., Kupsky W. J., Garcea RL. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. New Engl J Med 1992; 326: 988–993
   PubMed Web of Science ®Google Scholar
• Buckler C. E., Salzman NP. Annotated nucleotide sequence and restriction site lists for selected papovavirus strains. The Papovaviridae. The Polyomaviruses, N.P. Salzman. New York, Plenum Press 1986; Volume 1: 379–387
   Google Scholar
• Butel JS. Simian virus 40. Encyclopedia of Virology, R. G. Webster, A Granoff. Academic Pres, San Diego 1994; vol 3: 1322–1329
   Google Scholar
• Carbone M., Pass H. I., Rizzo P., Marinetti M. R., Di Muzio M., Mew D.J.Y, Levine A. S., Procopio A. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994; 9: 1781–1790
   PubMed Web of Science ®Google Scholar
• Carbone M., Rizzo P., Procopio A., Giuliano M., Pass H. I., Gebhardt M. C., Mangham C., Hansen M., Malkin D. F., Bushart G., Pompetti F., Picci P., Levine A. S., Bergsagel J. D., Garcea RL. SV40-like sequences in human bone tumors. Oncogene 1996; 13: 527–535
   PubMed Web of Science ®Google Scholar
• Chang D., Liou Z. M., Ou W. C., Wang K. Z., Wang M., Fung C. Y., Tsai RT. Production of the antigen and the antibody of the JC virus major capsid protein VPl. J Virol Meth 1996; 59: 177–187
   PubMedGoogle Scholar
• Cole CN. Polyomavirinae: the viruses and their replication. Fields Virology, 3rd, B.N. Fields, et al. Lippincott-Rave, Philadelphia 1996; 1997–2025
   Google Scholar
• Cristaudo A., Vivaldi A., Sensales G., Guglielmi G., Cianca E., Elisei R., Ottenga F. Molecular biology studies on mesothelioma tumor samples: preliminary data on H-Ras, p21 and SV40. J Environ Pathol Toxicol Oncol 1995; 14: 29–34
   PubMedGoogle Scholar
• Eddy B. E., Borman G. S., Berkeley W. H., Young RD. Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 1961; 107: 191–197
   Google Scholar
• Eddy B. E., Borman G. S., Grubbs G. E., Young RD. Identification of the oncogenic substance in rhesus monkey kidney cell cultures as simian virus 40. Virology 1962; 17: 65–75
   PubMed Web of Science ®Google Scholar
• Fanning E. Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J Virol 1992; 66: 1289–1293
   PubMedGoogle Scholar
• Fiers W., Contreras R., Haegeman G., Rogiers R., Van De Voorde A., Van Heuverswyn H., Van Herreweghe J., Volckaert G., Ysebaert M. Complete nucleotide sequence of SV40 DNA. Nature 1978; 273: 113–120
   PubMed Web of Science ®Google Scholar
• Frisque R.J.J.C., Viruses B.K. Encyclopedia of Virology, R. G. Webster, A. Granoff. Academic Pres, San Diego 1994; vol 2: 752–757
   Google Scholar
• Geissler E. SV40 and human brain tumors. Prog Med Virol 1990; 37: 211–222
   PubMedGoogle Scholar
• Geissler E., Konzer P., Scherneck S., Zimmermann W. Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40. Acta Virol 1985; 29: 420–423
   PubMedGoogle Scholar
• Girardi AJ. Prevention of SV40 virus oncogenesis in hamsters, I. Tumor resistance induced by human cells transformed by SV40. Proc Natl Acad Sci USA 1965; 54: 445–451
   PubMed Web of Science ®Google Scholar
• Girardi A. J., Sweet B. H., Slotnick V. B., Hilleman MR. Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV40. Proc Soc Exp Biol Med 1962; 109: 649–660
   PubMed Web of Science ®Google Scholar
• Hampil B. 1973, Personal communication.
   Google Scholar
• Hsiung G. D., Gaylord WH, Jr. The vacuolating virus of monkeys. I. Isolation, growth characteristics, and inclusion body formation. J Exp Med 1961; 114: 975–985
   Google Scholar
• Ilyinskii P. O., Daniel M. D., Horvath C. J., Desrosiers RC. Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J Virol 1992; 66: 6353–6360
   PubMedGoogle Scholar
• Jay G., Nomura S., Anderson C. W., Khoury G. Identification of the SV40 agnogene product: a DNA binding protein. Nature 1981; 291: 346–349
   PubMed Web of Science ®Google Scholar
• Krieg P., Amtmann E., Jonas D., Fischer H., Zang K., Sauer G. Episomal simian virus 40 genomes in human brain tumors. Proc Natl Acad Sci USA 1981; 78: 6446–6450
   PubMed Web of Science ®Google Scholar
• Krieg P., Scherer G. Cloning of SV40 genomes from human brain tumors. Virology 1984; 138: 336–340
   Google Scholar
• Lednicky J. A., Butel JS. Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol 1997; 78: 1697–1705
   Google Scholar
• Lednicky J. A., Garcea R. L., Bergsagel D. J., Butel JS. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 1995a; 212: 710–717
   PubMed Web of Science ®Google Scholar
• Lednicky J. A., Stewart A. R., Jenkins JJ, Finegold M. J., Butel JS. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer 1997; 72: 791–800
   PubMed Web of Science ®Google Scholar
• Lednicky J. A., Wong C., Butel JS. Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776. Virus Res 1995b; 35: 143–153
   Google Scholar
• Liddington R. C., Yan Y., Moulai J., Sahli R., Benjamin T. L., Harrison SC. Structure of simian virus 40 at 3.8 Å resolution. Nature 1991; 354: 278–284
   PubMed Web of Science ®Google Scholar
• Martin JD. Regulatory sequences of SV40 variants isolated from patients with progressive multifocal leukoencephalopathy. Virus Res 1989; 14: 85–94
   Google Scholar
• Martin J. D., Li P. Comparison of regulatory sequences and enhancer activities of SV40 variants isolated from patients with neurological diseases. Virus Res 1991; 19: 163–172
   Google Scholar
• Martini F., Iaccheri L., Lazzarin L., Carinci P., Corallini A., Gerosa M., Iuzzolino P., Barbanti-Brodano G., Tognon M. SV40 region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996; 56: 4820–4825
   PubMed Web of Science ®Google Scholar
• Meinke W., Goldstein D. A., Smith RA. Simian virus 40-related DNA sequences in a human brain tumor. Neurology 1979; 29: 1590–1594
   PubMed Web of Science ®Google Scholar
• Melnick J. L., Stinebaugh S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 1962; 109: 965–968
   PubMed Web of Science ®Google Scholar
• Pepper C., Jasani B., Navabi H., Wynford-Thomas D., Gibbs AR. Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax 1996; 51: 1074–1076
   PubMed Web of Science ®Google Scholar
• Pipas JM. Mutations near the carboxyl terminus of the simian virus 40 large tumor antigen alter viral host range. J Virol 1985; 54: 569–575
   Google Scholar
• Reddy V. B., Thimmappaya B., Dhar R., Subramanian K. N., Zain B. S., Pan J., Ghosh P. K., Celma M. L., Weissman SM. The genome of simian virus 40. Science 1978; 200: 494–502
   PubMed Web of Science ®Google Scholar
• Salzman N. P., Natarajan V., Selzer GB. Transcription of SV40 and polyoma virus and its regulation. The Papovaviridae. The Polyomaviruses, NP Salzman. Plenum Pres, New York 1986; Vol. 1: 27–98
   Google Scholar
• Scherneck S., Rudolph M., Geissler E., Vogel F., LÜBbe L., WÄHlte H., Nisch G., Weickmann F., Zimmermann W. Isolation of a SV40-like papovavirus from a human glioblastoma. Int J Cancer 1979; 24: 523–531
   PubMed Web of Science ®Google Scholar
• Shah KV. Polyomaviruses. Fields Virology, 3rd, BN Fields, et al. Lippincott-Raven, Philadelphia 1996; 2027–2043
   Google Scholar
• Shah K. V., Mccrumb FR, Jr., Daniel R. W., Ozer HL. Serologic evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst 1972; 48: 557–561
   PubMedGoogle Scholar
• Shah K. V., Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976; 103: 1–12
   PubMed Web of Science ®Google Scholar
• Shah K. V., Ozer H. L., Pond H. S., Palma L. D., Murphy GP. SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature 1971; 231: 448–449
   Google Scholar
• Soriano F., Shelburne C. E., GÖKcen M. Simian virus 40 in a human cancer. Nature 1974; 249: 421–424
   Google Scholar
• Spence S. L., Pipas JM. Simian virus 40 large T antigen host range domain functions in virion assembly. J Virol 1994; 68: 4227–4240
   Google Scholar
• Stewart A. R., Lednicky J. A., Benzick U. S., Tevethia M. J., Butel JS. Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology 1996; 221: 355–361
   Google Scholar
• Stinebaugh S., Melnick JL. Plaque formation by vacuolating virus. Virology 1962; 16: 348–349
   Google Scholar
• Sweet B. H., Hilleman MR. The vacuolating virus, S.V.40. Proc Soc Exp Biol Med 1960; 105: 420–427
   PubMed Web of Science ®Google Scholar
• Tevethia S. S., Butel JS. Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells. Intervirology 1973/74; 2: 200–205
   Google Scholar
• Tornow J., Polvino-Bodnar M., Santangelo G., Cole CN. Two separable functional domains of simian virus 40 large T antigen: Carboxyl-terminal region of simian virus 40 large T antigen is required for efficient capsid protein synthesis. J Virol 1985; 53: 415–424
   Google Scholar
• Weiner L. P., Herndon R. M., Narayan O., Johnson R. T., Shah K., Rubinstein L. J., Preziosi T. J., Conley FK. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 1972; 286: 385–390
   PubMed Web of Science ®Google Scholar
• Woloschak M., Yu A., Post KD. Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction. Cancer 1995; 76: 490–496
   PubMed Web of Science ®Google Scholar
• Zimmermann W., Scherneck S., Geissler E. Quantitative determination of papovavirus IgG antibodies in sera from cancer patients, labworkers and several groups of control persons by enzyme-linked immunosorbent assay (ELISA). Zbl Bakt Hyg I Abt Orig A 1983; 254: 187–196
   Google Scholar